PubMed Health⌕ Search

Biomedical subjects

A Majský

Publications and source records attributed to A Majský.

9 recordsLinked to original sources

HLA system and neurofibromatosis (von Recklinghausen's disease). Familial studies.

The authors performed HLA typing in 18 patients affected by neurofibromatosis (NF) and in 13 of them they also typed all the available members of their families. In 9 families manifesting a kindred occurrence further 16 patients, in whom the disease had not yet been diagnosed, have been unveiled. In 8 families our of nine manifesting a familial load of the disease there was agreement in one HLA haplotype eventually HLA identity among the diseased sibling members. From this point of view it appears that HLA typing in NF might be a valuable contribution especially for the diagnosis of the complete cases in families manifesting a kindred type of NF occurrence. Since NF is a disease perilous through its life endangering complications of a malignant character the authors recommend its dispensation and a concentration of all the NF affected patients and their relatives into a limited number of clinical establishments endowed with a possibility of cooperation with some HLA laboratory.

Adult↗

The inhibitory effect of methyl palmitate on heteroagglutinin formation in rats.

In Wistar rats the immunosuppressive effect of methyl palmitate on the formation of heteroagglutinins against human O-group erythrocytes was followed. An i.v. injection of methyl palmitate both delayed the heteroagglutinin formation and decreased its intensity. The inhibitory effect of methyl palmitate was not accompained by the subsequent hyperactive phase as could be observed in the previous experiments using ethyl palmitate.

ABO Blood-Group System↗

The formation of heteroagglutinins in rats "chemically" splenectomized by ethyl palmitate, in comparison to animals surgically splenectomized.

In Wistar rats "chemically splenectomized" by an i.v. injection of ethyl palmitate the formation of heteroagglutinins against human O-erythrocytes has been followed. Ethyl palmitate applied 2 hrs before immunization induced on the 5th day a significant decrease of the antibody level. This temporary inhibition, however, was at a later stage replaced by a significant increase of antibody level with the peak of 8--14 days. Animals surgically splenectomized 24 hrs prior to immunization displayed a weak antibody response throughout the experiment. An injection of the ethyl palmitate on the 6th day after immunization induced a pronounced and persistent decrease of the antibody level. Surgical splenectomy performed within the same interval had a comparable effect. The experiments revealed that the inhibitory effect of ethyl palmitate on antibody production was temporary only, and at a later stage could be compensated by an enhanced antibody activity.

Agglutinins↗